Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer

BACKGROUND: Luminal subtype breast cancer accounts for a predominant number of breast cancers. Considering the heterogeneity of the disease, it is urgent to develop novel biomarkers to improve risk stratification and optimize therapy choices. Long non-coding RNA (lncRNA) represents an emerging and u...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Fan, Lv, Shi-Xu, Lv, Lin, Liu, Ye-Huan, Dong, Si-Yang, Yao, Zhi-Han, Dai, Xuan-xuan, Zhang, Xiao-Hua, Wang, Ou-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117955/
https://www.ncbi.nlm.nih.gov/pubmed/27895496
http://dx.doi.org/10.2147/OTT.S110055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117955/
https://www.ncbi.nlm.nih.gov/pubmed/27895496
http://dx.doi.org/10.2147/OTT.S110055

Ejemplares similares